FDA approves Zelboraf

The USFDA has approved Zelboraf (vemurafenib), which is approved for treatment of patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

Source: www.fda.gov